Steris (STE) Tops Q4 EPS by 2c

Go back to Steris (STE) Tops Q4 EPS by 2c

STERIS (STE) PT Lowered to $248 at Needham & Company

May 12, 2022 12:46 PM EDT

Needham & Company analyst Mike Matson lowered the price target on STERIS (NYSE: STE) to $248.00 (from $263.00) while maintaining a Buy rating following earnings.

The analyst commented, "STE's F4Q22 revenue and EPS beat consensus. Organic revenue growth improved from the prior quarter overall and in all... More